The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relacorilant (RELA) with nab-paclitaxel (NP): Safety and activity in patients with pancreatic ductal adenocarcinoma (PDAC) and ovarian cancer (OvCA).
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Jasgit C. Sachdev
Honoraria - Celgene; Novartis; Puma Biotechnology; Tempus
Consulting or Advisory Role - Celgene
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Celgene
 
Gini F. Fleming
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Corcept Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Erkut Hasan Borazanci
Consulting or Advisory Role - Biogen (I); Corcep; Fujifilm; Genzyme (I); Ipsen; Novartis (I); Teva (I)
Speakers' Bureau - Biogen (I); Genentech (I); Genzyme (I); Ipsen; Novartis (I); Taiho Pharmaceutical; Teva (I)
Research Funding - Ambry Genetics (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Idera (Inst); Lilly (Inst); MabVax (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst); Samumed (Inst)
 
Jennifer A. Grabowsky
No Relationships to Disclose
 
Manish Sharma
Consulting or Advisory Role - Abbvie; Bayer; Eisai; Ipsen; Taiho Pharmaceutical
 
Joseph Custodio
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Andrew Greenstein
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Lawrence Lu
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Dat Nguyen
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Stacie Peacock Shepherd
Employment - Abbvie; Corcept Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Calithera Biosciences; Corcept Therapeutics